Begrivac

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug; Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug; Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug

Disponibbli minn:

Novartis New Zealand Ltd

INN (Isem Internazzjonali):

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg

Dożaġġ:

0.5 mL

Għamla farmaċewtika:

Suspension for injection

Kompożizzjoni:

Active: Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug Excipient: Ether Formaldehyde Phosphate Buffered Saline Polymyxin B Polysorbate 80 Sucrose

Unitajiet fil-pakkett:

Syringe, glass, Prefilled single 0.5ml dose, 1 dose unit

Klassi:

Prescription

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

GSK Vaccines GmbH

Sommarju tal-prodott:

Package - Contents - Shelf Life: Syringe, glass, Prefilled single 0.5ml dose - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, glass, 0.5mL syringe, 10 pack - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Data ta 'l-awtorizzazzjoni:

1999-11-12